Total protein and albumin measure the amount of protein, electrophoresis shows its distribution among fractions, and immunochemical and mass spectrometric methods identify individual proteins, including the protein responsible for an abnormal result. Interpretation depends on the method, specimen, pattern, and clinical setting.
Amino acids
An amino acid contains an amino group, a carboxyl group, a hydrogen atom, and a variable side chain attached to an alpha carbon. The side chain determines charge, polarity, and many of the chemical interactions that shape a protein. At physiologic pH, most free amino acids contain both a positively charged amino group and a negatively charged carboxyl group. This dipolar form is a zwitterion. The pH at which a molecule has no net electrical charge is its isoelectric point, or pI.1
A peptide bond joins the carboxyl group of one amino acid to the amino group of another and releases water. Two joined residues form a dipeptide; longer chains form polypeptides. Protein digestion reverses these bonds by hydrolysis. Gastric acid unfolds dietary proteins, and pepsin begins proteolysis. Secretin promotes pancreatic bicarbonate secretion to neutralize acid in the duodenum, and cholecystokinin promotes secretion of pancreatic proteases. Trypsin, chymotrypsin, elastase, and carboxypeptidases produce smaller peptides. Brush-border and intracellular peptidases complete digestion, and transporters carry amino acids and small peptides into enterocytes for delivery to the portal circulation.1
Nutritional requirements vary with age, growth, illness, and metabolic defects, so the adult categories below are only a starting point.1
Scroll sideways to see all columns
| Category | Amino acids | Laboratory point |
|---|---|---|
| Essential in adults | Histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, valine | Dietary intake supplies these amino acids. |
| Synthesized in the body | Alanine, asparagine, aspartate, glutamate, serine | Endogenous synthesis usually meets the requirement. |
| Conditionally essential | Arginine, cysteine, glutamine, glycine, proline, tyrosine | Growth, severe illness, or a metabolic defect may make endogenous supply inadequate. Tyrosine becomes conditionally essential when phenylalanine hydroxylation is impaired, as in phenylketonuria. |
Leucine, isoleucine, and valine are the branched-chain amino acids. Their shared early catabolic steps help produce the characteristic profile in maple syrup urine disease.
Selenocysteine is a specialized selenium-containing amino acid. Cells synthesize it on its transfer RNA from serine and insert it during programmed recoding of selected UGA codons. It does not fit the ordinary dietary classification used for the 20 standard amino acids.1
Quantitative plasma amino acids
Quantitative amino acid profiles support the investigation and monitoring of inherited metabolic disorders. Interpret the concentrations together, taking account of the patient's age, fasting state, diet, medications, treatment, and condition at collection.
Aminoacidopathies result from defects in an enzyme, cofactor, or transporter. A profile may show a deficient product, an accumulated substrate, or metabolites produced through alternate pathways. Prompt recognition and treatment are necessary when accumulated compounds are neurotoxic. Cells continue to metabolize amino acids after collection, so delayed separation or transfer of the buffy coat can change the measured pattern.1,2
Collection and handling are method-specific. One current liquid chromatography with tandem mass spectrometry procedure requires a 4-hour fast for older children and adults, sodium-heparin plasma, wet ice after collection, separation immediately or within 4 hours under refrigeration, transfer without buffy coat, and frozen transport. That procedure does not measure total homocysteine, so a separate assay is required when a homocysteine disorder is under investigation. Collect the specimen your laboratory's instructions name.2
Protein structure, synthesis, and classification
Protein structure is described at four levels.
Scroll sideways to see all columns
| Level | Description | Change that can disrupt it |
|---|---|---|
| Primary | Amino acid sequence joined by peptide bonds | Mutation, chemical cleavage, or proteolysis |
| Secondary | Local alpha helices, beta sheets, and turns stabilized mainly by hydrogen bonds | Heat, pH change, solvents, and other conditions that disrupt weak interactions |
| Tertiary | Three-dimensional folding of one polypeptide, including hydrophobic, ionic, hydrogen-bond, and disulfide interactions | Denaturing conditions or altered residues |
| Quaternary | Association of two or more polypeptide subunits | Conditions that separate or misassemble subunits |
Denaturation changes secondary, tertiary, or quaternary structure and usually impairs function. Peptide-bond cleavage changes primary structure and is proteolysis or degradation. This distinction matters because a denatured protein can retain its amino acid sequence while losing activity or solubility.1
Ribosomes translate messenger RNA into polypeptides. Folding, cleavage, glycosylation, phosphorylation, and other post-translational changes produce the mature protein. Hepatocytes make albumin, transferrin, fibrinogen, and many complement and coagulation proteins. Plasma cells make immunoglobulins, and tissue-specific proteins enter blood from other organs.
Proteins can be classified by shape or composition. Globular proteins include albumin, enzymes, and immunoglobulins. Fibrous proteins include collagen and fibrin. A simple protein yields amino acids when completely hydrolyzed. A conjugated protein also contains a nonprotein component. Hemoglobin is a hemoprotein, lipoproteins carry lipid, metalloproteins bind a metal, glycoproteins and proteoglycans contain carbohydrate, and nucleoproteins contain nucleic acid. Immunoglobulins are glycoproteins.1
Protein solubility often reaches a minimum near the pI because reduced net charge decreases electrostatic repulsion among molecules. In isoelectric focusing, a protein migrates through a stable pH gradient until it reaches the pH that matches its pI. The method's high resolution allows it to resolve cerebrospinal fluid oligoclonal bands.
Protein turnover continually releases amino acids for reuse or catabolism. Nitrogen balance is the difference between nitrogen intake and nitrogen loss. Transamination transfers an amino group to an alpha-keto acid, and oxidative deamination can release ammonia. The liver converts much of that nitrogen to urea. The remaining carbon skeleton is glucogenic, ketogenic, or both according to the pathway it enters.1
Plasma proteins by electrophoretic fraction
At the alkaline pH commonly used for serum protein electrophoresis, most major serum proteins have a net negative charge. They migrate toward the anode at rates determined mainly by charge, with size, shape, support medium, and electro-osmotic effects also contributing. The familiar fractions are prealbumin, albumin, alpha-1, alpha-2, beta, and gamma.1
Scroll sideways to see all columns
| Fraction | Representative proteins | Interpretation |
|---|---|---|
| Prealbumin | Transthyretin | Transports thyroxine and retinol-binding protein. Concentration falls during inflammation and changes with hepatic and renal disease. |
| Albumin | Albumin | Maintains much of plasma colloid osmotic pressure and transports bilirubin, fatty acids, calcium, hormones, drugs, and other ligands. |
| Alpha-1 | Alpha-1 antitrypsin, alpha-1 acid glycoprotein, alpha-fetoprotein | Alpha-1 antitrypsin and alpha-1 acid glycoprotein are positive acute-phase proteins. Alpha-1 acid glycoprotein also binds many basic drugs. |
| Alpha-2 | Haptoglobin, alpha-2 macroglobulin, ceruloplasmin | Haptoglobin binds free hemoglobin. Alpha-2 macroglobulin often becomes prominent when smaller proteins are lost in urine. Ceruloplasmin carries most circulating copper. |
| Beta | Transferrin, complement C3, beta lipoprotein, hemopexin | Transferrin transports iron and is a negative acute-phase protein. Complement, lipoprotein, and some monoclonal proteins contribute to this region. |
| Gamma | Immunoglobulins | Broad increases usually reflect many immunoglobulin clones. A restricted immunoglobulin can form a narrow peak, although its position can be beta or, less often, alpha. |
Immunoglobulin chain structure, classes, class switching, and antibody function are covered in Immune System Physiology and Immunoglobulins. That biology guides the interpretation of quantitative immunoglobulin, electrophoresis, immunofixation, and free light-chain results.
Albumin and transthyretin concentrations reflect inflammation, distribution, synthesis, and loss. Neither is a stand-alone measure of body protein stores or muscle mass.3 Low albumin can result from inflammation, reduced hepatic synthesis, renal or gastrointestinal loss, increased catabolism, dilution, or movement into the extravascular space. Hyperalbuminemia usually reflects reduced plasma water. Increased synthesis is rarely the cause.
Glycated albumin reflects shorter-term glycemia but is method dependent. Myoglobin is interpreted with heme proteins and muscle injury. Cystatin C and beta-2-microglobulin require renal filtration and tubular context, which is covered in Renal Physiology, Function Testing, and Disease Patterns. Cardiac troponins and natriuretic peptides require tissue-injury and disease-marker context. Alpha-fetoprotein, fetal fibronectin, and bone-turnover proteins also require indication-specific methods and decision limits. Their concentration alone does not define a diagnosis.
Total protein and albumin: methods and interpretation
Measurement methods
Scroll sideways to see all columns
| Analyte | Common principle | Main analytical point |
|---|---|---|
| Total protein in serum or plasma | Biuret reaction | Cupric ions react with peptide bonds in alkaline solution to form a colored complex. The signal is proportional to protein concentration. Biuret spectrophotometry is also used in a higher-order reference measurement service.4 |
| Albumin | Bromocresol green or bromocresol purple dye binding | The dye-protein complex changes absorbance. Selectivity and bias depend on the dye formulation, reaction conditions, platform, and patient sample. Bromocresol green methods can react with nonalbumin proteins. Current standardization work calls for replacing nonselective procedures where bias can affect care.5 |
| A named protein | Immunoturbidimetry or immunonephelometry | Antigen-antibody complexes scatter light. Calibration, antigen excess checks, antibody specificity, and the validated measuring interval affect the result. |
| Electrophoretic fraction | Densitometric or capillary signal percentage multiplied by total protein | Fraction concentration inherits uncertainty from both measurements and depends on correct peak boundaries. |
The validated reagent and platform procedure specifies measurement wavelength and reaction timing. In one current biuret reagent, tartrate prevents copper hydroxide precipitation and iodide prevents copper autoreduction.6 Ultraviolet absorbance near 280 nm detects aromatic amino acids. It lacks selectivity in a mixture such as serum. Protein stains, including amido black, Ponceau S, and Coomassie dyes, visualize separated bands. Immunoassays add molecular specificity when the target is a named protein. Bilirubin, hemoglobin, globulin composition, renal disease, and specimen matrix can produce method-dependent albumin dye bias, so review results against the procedure's interference data.1,5
Serum and plasma total protein are similar, but plasma retains fibrinogen. Serum is preferred for serum protein electrophoresis because residual fibrinogen can create a band between the beta and gamma regions. Prolonged tourniquet use and standing can concentrate proteins through loss of plasma water. Intravenous fluid contamination can dilute them. For a hemolyzed, lipemic, or icteric specimen, follow your laboratory's interference and specimen-acceptance rules for that assay.6
Reference intervals depend on age, specimen, assay, and laboratory population. Interpret results against the interval supplied with the report. A high total protein result can reflect dehydration or increased globulins, including polyclonal or monoclonal immunoglobulins. A low result can reflect dilution, reduced synthesis, protein loss, or increased catabolism. Total protein can remain within its interval when one fraction rises as another falls.
Calculated globulin and the albumin/globulin ratio use total protein and albumin from the same specimen in the same units:
calculated globulin = total protein − albumin
albumin/globulin ratio = albumin ÷ calculated globulin
A zero calculated globulin makes division undefined, and a negative calculated globulin means the measured components are inconsistent. The arithmetic appears in Core Chemistry Calculations.
Protein electrophoresis
Separation and measurement
Agarose gel electrophoresis commonly uses an alkaline buffer near pH 8.4 to 8.8 and separates serum proteins into bands, which are stained and scanned by a densitometer. Capillary zone electrophoresis separates proteins in narrow capillaries and measures absorbance directly as they pass a detector. Both systems commonly report albumin, alpha-1, alpha-2, beta, and gamma fractions, and their fraction boundaries, resolution, and interference patterns differ. High-resolution agarose and capillary methods can resolve additional bands. The number of bands is platform-dependent. Isoelectric focusing separates proteins by pI and is especially useful for restricted immunoglobulin bands in cerebrospinal fluid. Laboratories validate the method, review flagged traces, and establish their own reference intervals.1
An absolute fraction concentration can be calculated from its densitometric percentage and the total protein measured on the same specimen. Suppose albumin is 60% of a total protein concentration of 6.8 g/dL:
albumin fraction = 0.60 × 6.8 g/dL = 4.08 g/dL
This estimate inherits error from the total-protein assay, trace integration, and peak-boundary selection.
Electrophoretic mobility relates migration distance to time and electric field strength:
mobility (cm²/[V·s]) = migration distance (cm) ÷ [time (s) × field strength (V/cm)]
Suppose a band travels 4.2 cm in 4,200 seconds at 10 V/cm:
mobility = 4.2 ÷ (4,200 × 10) = 0.00010 cm²/(V·s)
The calculation describes movement under the stated conditions. It does not make results from different buffers, temperatures, support media, or instruments interchangeable.
Pattern recognition
Scroll sideways to see all columns
| Pattern | Typical distribution | Interpretation boundary |
|---|---|---|
| Acute inflammatory response | Albumin may fall; alpha-1 and alpha-2 fractions rise | Positive and negative acute-phase proteins change at different rates. The trace does not identify the cause. |
| Polyclonal response | Broad gamma-region increase, sometimes with beta-gamma continuity | Many immunoglobulin clones are contributing. Chronic inflammation, infection, liver disease, and autoimmune disease are common settings. |
| Monoclonal pattern | Narrow, restricted peak or band in gamma, beta, or occasionally alpha region | Confirm identity with immunofixation or an equivalent method. Peak size and location do not establish the underlying disorder. |
| Nephrotic pattern | Low albumin, prominent alpha-2 region, often increased beta and reduced gamma | Urinary loss favors smaller proteins. Retained alpha-2 macroglobulin contributes to the alpha-2 rise. |
| Cirrhotic pattern | Low albumin with a broad beta-gamma bridge | Polyclonal immunoglobulin increase, especially IgA migration toward beta, can reduce the separation between regions. |
| Hypogammaglobulinemia | Reduced gamma region | Quantitative immunoglobulins and the clinical setting define the significance. A small monoclonal protein can still be present. |
| Alpha-1 antitrypsin deficiency pattern | Reduced alpha-1 region | Phenotype, genotype, or a specific quantitative assay is needed because inflammation can raise the concentration. |
Electrophoretic patterns narrow the differential. Interpret them with the specimen, the quantitative results, and the clinical context.1,7
An inherited or acquired bisalbuminemia can split the albumin peak. The paired peaks have little clinical effect by themselves. Recognizing the pattern keeps an albumin variant from being mistaken for a restricted globulin.1
Several artifacts can mimic an abnormal pattern. Plasma fibrinogen may form a restricted band near the beta-gamma interface. Hemolysis can add hemoglobin-related bands and complicate haptoglobin interpretation. High C-reactive protein can form a restricted band on some systems. Radiographic contrast, certain antimicrobials, and therapeutic monoclonal antibodies can also alter a trace. Previous results, specimen type, medication history, and confirmatory testing help resolve these findings.1,7
Monoclonal protein studies
A monoclonal protein is an immunoglobulin or immunoglobulin component produced by one clone. The laboratory finding can accompany monoclonal gammopathy of undetermined significance, plasma-cell neoplasms, lymphoplasmacytic disorders, amyloid light-chain amyloidosis, and other conditions. A monoclonal IgM result occurs in several of these disorders, so isotype alone does not establish the diagnosis. The immune disease lesson covers the clinical categories.
Current College of American Pathologists guidance supports this initial laboratory approach when a monoclonal gammopathy is suspected:7
- Perform serum protein electrophoresis and serum free light chains.
- If serum electrophoresis shows a monoclonal protein or the serum free light-chain ratio is abnormal, perform serum immunofixation or a validated equivalent.
- For suspected amyloid light-chain amyloidosis, order serum protein electrophoresis, serum free light chains, serum immunofixation, and urine immunofixation together because the monoclonal protein may be very small.
- Correlate all results because no single method detects every monoclonal protein.
Immunofixation electrophoresis separates proteins in parallel lanes and applies antisera to heavy and light chains. A restricted band that reacts with one heavy-chain reagent and one light-chain reagent identifies the isotype. Immunofixation is more sensitive than routine serum protein electrophoresis for small proteins, and it is primarily qualitative. Immunosubtraction can provide an equivalent identification step on validated capillary systems. Some laboratories use mass spectrometry to distinguish endogenous monoclonal proteins from therapeutic antibodies or to characterize difficult findings. If a restricted kappa or lambda band has no associated IgG, IgA, or IgM band, test for IgD and IgE before you report the protein as light-chain only.7
Serum free light-chain testing measures unbound kappa and lambda light chains and calculates a kappa/lambda ratio. Renal impairment can raise both concentrations and change the expected ratio. Inflammation can also raise both. Assays differ in calibration and antibody reactivity, so the method's reference interval and renal interpretation rules apply. Antigen excess, nonlinearity, polymerization, and lot-to-lot behavior are additional analytical concerns.8
When a restricted peak can be measured reliably, densitometry estimates the M-protein concentration. Co-migration with transferrin, complement, or another protein can make that estimate inaccurate, especially in the beta region. A small peak may still be clinically important, and a large peak can be analytically difficult. Keep serial M-protein measurements on the same method whenever possible.
Proteins in urine
Urine protein testing distinguishes albumin-predominant glomerular loss, low-molecular-weight tubular protein loss, overflow of a filtered protein, and protein from postrenal inflammation or bleeding. The reagent-strip lesson covers the protein error of indicators, the strip's albumin preference, and confirmatory testing. Quantitative studies add concentration, creatinine normalization, and protein identity.
Scroll sideways to see all columns
| Test | What it measures | Main limitation |
|---|---|---|
| Urine total protein | Dye-binding or turbidimetric response to multiple proteins | Different proteins do not produce equal responses, and methods are not interchangeable. |
| Urine albumin | Usually an immunoturbidimetric or immunonephelometric assay | Calibration and molecular forms of albumin can produce method-dependent bias. |
| Albumin-to-creatinine ratio (ACR) | Albumin normalized to urine creatinine | Creatinine excretion and within-person variation affect the ratio. |
| Protein-to-creatinine ratio (PCR) | Total protein normalized to urine creatinine | Response depends on the protein mixture and total-protein method. |
| Urine protein electrophoresis and immunofixation | Distribution and identity of a monoclonal protein | Concentration, urine volume, renal handling, and collection quality affect detection. |
Automated urine total-protein assays commonly use dye-binding or turbidimetric reactions. Pyrogallol red-molybdate provides sensitivity at urine concentrations. Precipitation methods such as sulfosalicylic acid detect several protein classes but are affected by specimen turbidity, drugs, and radiographic contrast. Modified biuret and Folin-based methods also exist. These reactions have unequal responses to albumin, immunoglobulin light chains, and low-molecular-weight proteins, and no current higher-order system makes results from all manufacturers interchangeable.9
Urine protein electrophoresis can support the mechanism of proteinuria. An albumin-dominant trace supports glomerular loss. Multiple low-molecular-weight bands support impaired tubular reabsorption. A restricted free light-chain band supports overflow proteinuria and requires immunofixation for identity. Mixed and postrenal patterns occur, so the trace does not establish the diagnosis by itself.1,7
Kidney Disease: Improving Global Outcomes classifies albuminuria by ACR as A1 below 30 mg/g, A2 from 30 through 300 mg/g, and A3 above 300 mg/g. The equivalent SI decision points are below 3, from 3 through 30, and above 30 mg/mmol. Confirm a random ACR at or above 30 mg/g when appropriate, preferably with a subsequent first-morning void, because exercise, infection, menstruation, hydration, and day-to-day biological variation can affect a result.10,11
Suppose urine albumin is 66 mg/L and urine creatinine is 1.50 g/L.
ACR = 66 mg/L ÷ 1.50 g/L = 44 mg/g
The liters cancel, leaving milligrams of albumin per gram of creatinine. This result is in category A2. The category describes albumin excretion and is interpreted together with persistence, estimated glomerular filtration rate, and the clinical setting.
Suppose urine total protein is 52 mg/dL and urine creatinine is 104 mg/dL.
PCR = 52 ÷ 104 = 0.50 mg/mg = 500 mg/g
The local method and clinical pathway determine interpretation of PCR. Timed excretion calculations and collection checks are in Timed Urine and Renal Clearance Calculations.
Serum protein electrophoresis, serum immunofixation, and serum free light chains detect most monoclonal gammopathies more effectively than a urine screen alone. Urine immunofixation is used in selected settings, including suspected amyloid light-chain amyloidosis and some monoclonal kidney disorders. A 24-hour urine collection may be requested when quantitative urinary M-protein excretion is needed.7
Proteins in cerebrospinal fluid
Cerebrospinal fluid contains far less protein than serum. Concentration varies with age and collection site. Lumbar fluid usually contains more protein than ventricular fluid. Blood contamination can add albumin and immunoglobulins. Quantitative methods therefore need a measuring interval and blank appropriate for low concentrations. Laboratories may use reflectance, turbidimetric, dye-binding, or immunochemical methods, with method- and age-specific reference intervals. Increased total protein is nonspecific and can accompany blood-CSF barrier dysfunction, inflammation or infection, hemorrhage, impaired CSF flow, tumor, or demyelinating injury. Exam-only intervals are listed separately in ASCP BOC Examination Reference Ranges.1,12
After concentration, a normal CSF electrophoretic pattern can show prealbumin, albumin, alpha-1, alpha-2, beta, and gamma proteins. Albumin remains the largest fraction. Beta-1 transferrin is the serum form. Beta-2 transferrin, also called the tau fraction in older electrophoresis terminology, is a carbohydrate-deficient transferrin form found in CSF and used as a marker of CSF in nasal, otic, or wound fluid. Immunoglobulins contribute to the gamma region. Fraction names and migration positions depend on the platform.1,13
The albumin quotient evaluates transfer of a liver-derived protein across the blood-CSF barrier. Convert the paired CSF and serum albumin concentrations to the same units before division:
albumin quotient (QAlb) = CSF albumin ÷ serum albumin
Suppose CSF albumin is 180 mg/L and serum albumin is 40,000 mg/L:
QAlb = 180 ÷ 40,000 = 0.0045 = 4.5 × 10−3
QAlb decision limits are age- and procedure-dependent. An increased quotient supports impaired blood-CSF barrier function or altered CSF flow. It does not identify a cause.
The IgG index compares the CSF-to-serum IgG ratio with the paired albumin ratio:
IgG index = (CSF IgG ÷ serum IgG) ÷ (CSF albumin ÷ serum albumin)
Suppose CSF IgG is 4.0 mg/dL, serum IgG 1,000 mg/dL, CSF albumin 20 mg/dL, and serum albumin 4.0 g/dL (4,000 mg/dL):
IgG index = (4.0 ÷ 1,000) ÷ (20 ÷ 4,000) = 0.004 ÷ 0.005 = 0.80
One current laboratory procedure uses 0.70 as its upper reference limit, so 0.80 is increased for that procedure. An increased index supports intrathecal IgG production. It does not establish a specific neurologic diagnosis.14
Oligoclonal band testing uses isoelectric focusing followed by IgG-specific immunoblotting on paired CSF and serum. The serum comparison separates intrathecal bands from circulating bands that crossed into CSF.15
Scroll sideways to see all columns
| Paired pattern | Interpretation |
|---|---|
| Bands unique to CSF | Supports intrathecal IgG synthesis. One current procedure defines two or more unique CSF bands as positive; each laboratory validates its decision rule. |
| Matching bands in CSF and serum | Supports a systemic immune response with transfer into CSF. |
| Matching bands plus additional CSF-only bands | Supports both systemic and intrathecal immunoglobulin production. |
| No restricted bands | No oligoclonal IgG detected by the procedure. This result does not exclude inflammatory neurologic disease. |
Intrathecal IgG synthesis occurs in multiple sclerosis and in other inflammatory or infectious neurologic disorders. Myelin basic protein is a nonspecific marker of myelin injury. Alzheimer disease biomarker panels use procedure-specific combinations and decision limits. These results require the validated neurologic testing pathway. Cell counts, appearance, and infectious patterns are covered in Body Fluid Cell Counts and Cerebrospinal Fluid.
For every specimen type, report the protein pattern and the confirmatory test it requires. The pattern alone does not establish a diagnosis.
Practice
References
- Bishop ML, Fody EP, Van Siclen C, Mistler JM, Moy M. Clinical Chemistry: Principles, Techniques, and Correlations. 9th ed. Jones & Bartlett Learning; 2023. Back to text
- Mayo Clinic Laboratories. Amino Acids, Quantitative, Plasma. Accessed August 30, 2026. Back to text
- Evans DC, Corkins MR, Malone A, et al. The use of visceral proteins as nutrition markers: an ASPEN position paper. Nutr Clin Pract. 2021;36(1):22-28. doi:10.1002/ncp.10588 Back to text
- Joint Committee for Traceability in Laboratory Medicine. C1RMS118: total protein in blood serum, blood plasma. Updated August 29, 2025. Accessed August 30, 2026. Back to text
- Panteghini M, Auclair G, Thelen M, Wu L, Wielgosz R. A roadmap for standardization of serum albumin measurements. Clin Chem Lab Med. Published online August 24, 2026. doi:10.1515/cclm-2026-1215 Back to text
- Mayo Clinic Laboratories. Protein, Total, Serum. Accessed August 30, 2026. Back to text
- Keren DF, Bocsi G, Billman BL, et al. Laboratory detection and initial diagnosis of monoclonal gammopathies. Arch Pathol Lab Med. 2022;146(5):575-590. doi:10.5858/arpa.2020-0794-CP Back to text
- Mayo Clinic Laboratories. Immunoglobulin Free Light Chains, Serum. Accessed August 30, 2026. Back to text
- Miller WG, Seegmiller JC, Bachmann LM, Panteghini M. Measuring urine albumin and total protein. Nephrol Dial Transplant. 2026;41(suppl 2):ii4-ii11. doi:10.1093/ndt/gfag060 Back to text
- Kidney Disease: Improving Global Outcomes CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4S):S117-S314. doi:10.1016/j.kint.2023.10.018 Back to text
- Seegmiller JC, Bachmann LM. Urine albumin measurements in clinical diagnostics. Clin Chem. 2024;70(2):382-391. doi:10.1093/clinchem/hvad174 Back to text
- Mayo Clinic Laboratories. Protein, Total, Spinal Fluid. Accessed August 30, 2026. Back to text
- ARUP Laboratories. Beta-2 Transferrin. Test 0050047. Accessed September 7, 2026. Back to text
- Mayo Clinic Laboratories. Cerebrospinal Fluid IgG Index Profile, Serum and Spinal Fluid. Accessed September 7, 2026. Back to text
- Mayo Clinic Laboratories. Oligoclonal Banding, Serum and Spinal Fluid. Accessed August 30, 2026. Back to text